Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
algorithm
alien hand syndrome
AMPA receptor antibodies
amygdala
antithyroid antibodies
aphasia
aphasia, progressive, primary
apraxia
ataxia
ataxic gait
atypical
autoantibodies
autoimmune disease
autoimmune GFAP astrocytopathy
axonal degeneration
axonal injury
Babinski sign
basal ganglia
basal ganglia, infarction
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
biotin
biotin deficiency
biotin deficiency, juvenile form
biotin-responsive basal ganglia disease
blinking, reduced
brachium pontis
bradykinesia
brain atrophy
brain biopsy
brainstem, lesion of
carcinoma
carcinoma of lung
CAT scan
CAT scan, abnormal
CAT scan, chest
CD8 encephalitis
cerebellar lesion
cerebellum
cerebral cortex
cerebral cortical atrophy
cerebrospinal fluid, elevated protein of
cerebrovascular accident
cerebrovascular disease
children
chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
Clinical Pathologic Conference(C.P.C.)
cognition
compulsivity
confusion
contractures, joint
cortical-basal ganglionic degeneration
deep gray nuclei
degenerative diseases of CNS
dementia
dementia, rapidly progressive
developmental milestones, loss of
diagnostic criteria
differential diagnosis
diplopia
dizziness
dopa responsive dystonia
dysarthria
dysmetria
dysphagia
dystonia
dystonia, children
dystonia, painful
edema, periorbital
efficacy
electrical stimulation
electroencephalogram, abnormalities of
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalopathy
encephalopathy, Hashimoto's
encephalopathy, progressive
enzyme, defect
extraocular muscle enlargement
extraocular muscle lesion
eye movement, disorders of
eye, pain in
falling
familial
fever
fluctuate
frontal behavioral spatial syndrome
gadolinium
gait disorder
galactorrhea
gaze palsy
gaze palsy, supranuclear
gaze palsy, vertical
gene
gene mutation
genetic neurologic disorders
genetic testing
GFAP-IgG
glabellar sign
glutamic acid decarboxylase, antibody
granulomatosis with polyangiitis
gyrus, abnormal
hallucination
head injury
headache
hemiparesis
heralding manifestation
herpes simplex encephalitis
hippocampus
hippocampus, hyperintense
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
human immunodeficiency virus type 1
hummingbird sign
hydrocephalus
hydrocephalus, non-communicating(obstructive)
hyperreflexia
hypertension
hypertonia
hyponatremia
hyporeflexia
imbalance
imbalance, postural
immunologic disease
immunosuppression
immunosuppressive agents
immunotherapy
inappropriate antidiuretic(A.D.H.)hormone
insular cortex
intellectual deterioration
L-dopa
leg weakness, bilateral
limbic encephalitis
limbic system
malignancy screen
masked facies
mediastinum, mass of
memory, defect of recent
memory, impairment of
meningeal enhancement
meningitis
meningoencephalitis
meningoencephalomyelitis
mental status, abnormal
mesial temporal lobe
methotrexate
midbrain
midbrain, atrophy
mimics
misdiagnosis
movement disorder
movement disorder, extrapyramidal
MRI
MRI pattern
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, curvilinear pattern
MRI, contrast enhanced, high dose
MRI, curvilinear peppering enhancement
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, FLAIR
MRI, linear enhancement
MRI, mass effect on
MRI, negative
MRI, nodular enhancement
MRI, orbit
MRI, punctate pattern
MRI, serial
MRI, spinal cord
MRS
muscle biopsy, extraocular
myelitis
myelitis, autoimmune
myelitis, longitudinal
myelopathy
myopathy, necrotizing
myopathy, steroid responsive
myositis
myositis, ocular
necrotizing vasculitis
neuroaxonal degeneration
neurologic disease, diagnoses of
neurologic disease, tempo
neurologic examination, focal
neurologic signs
neurologic symptoms
neuropathology
NMDA antagonists
nystagmus
nystagmus, gaze-evoked
nystagmus, upbeating on upgaze
nystagmus, upbeating-in primary position of gaze
obsessive-compulsive disorder
ophelia syndrome
optic neuropathy
orbit, biopsy
orbit, inflammation in
orbit, lesions of
orbital apex
oscillopsia
papillitis
paraparesis
Parkinson disease
Parkinson disease, arteriosclerotic
Parkinson disease, asymmetric onset
Parkinson disease, L-dopa nonresponsive
Parkinson disease, tremor, absence of
Parkinsonism syndrome
perivascular enhancement
perivascular inflammation
personality change
pleocytosis of cerebrospinal fluid
pons, atrophy
pons, lesion of
pontocerebellar atrophy
postural abnormality
prognosis
progressive neurologic disorder
progressive supranuclear palsy
prolactin, elevated
proptosis
proptosis, unilateral
psychiatric problems in neurologic disorders
ptosis
ptosis, unilateral
pyramidal tract dysfunction
recurrent
release phenomena
remote effect of cancer on the nervous system
responsive cortical stimulation
reversible neurologic disorder
review article
rigidity
risk factors
rituximab
saccadic eye movements, abnormal
safety
salivary gland enlargement
Saudi Arabia
scoliosis
scotoma
seizure
seizure, drug resistance
seizure, focal
seizure, intractable
seizure, intractable, treatment of
seizure, medication failure
seizure, surgical treatment of
seizure, treatment of
serologic testing
sialadenitis
snout reflex
spasticity
speech disorder
speech disorder, childhood
spinal cord, lesion of
splenium of corpus callosum
steroid responsive encephalitis
steroid responsive encephalopathy
steroid therapy, CNS treatment and complications with
striatum, lesion of
striatum, lesion of, bilateral
supratentorial lymphocytic inflam parenchy perivasc enhanc responsive to steroids
symmetric brain lesions
syphilis, neurologic complications with
tandem gait, ataxic
tau protein
tauopathy
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
thyroiditis
tonic foot response
transient neurologic deficit
treatment of neurologic disorder
tremor
tremor, postural
tyrosine hydroxylase deficiency
urinary incontinence
vasculitides
vertigo
visual field defect
visual loss
walking frame
walking, difficulty with
weakness
weight loss
wheelchair
white matter disease
wide based gait
workup
Showing articles 3500 to 3550 of 7873 << Previous Next >>

Hydrocephalus Is a Determinant of Early Mortality in Putaminal Hemorrhage
Stroke 31:2157-2162, Phan,T.G. et al, 2000

Prediction of Malignant Middle Cerebral Artery Infarction by Diffusion-Weighted Imaging
Stroke 31:2175-2181, Oppenheim,C. et al, 2000

Family Support for Stroke: a Randomised Controlled Trial
Lancet 356:808-813, Mant,J. et al, 2000

Alternative Strategies for Stroke Care: a Prospective Randomised Controlled Trial
Lancet 356:894-899,869, Kalra,L. et al, 2000

Long-Term Clinical and Angiographic Outcomes in Symptomatic Patients with 70% to 99% Carotid Artery Stenosis
Stroke 31:2037-2042, Paciaroni,M. et al, 2000

Neuroimaging in Deteriorating Patients with Cerebellar Infarcts and Mass Effect
Stroke 31:2062-2067, Koh,M.G. et al, 2000

Cerebrovascular Ischemic Events in Wind Instrument Players
Neurol 55:865-867, Evers, S. et al, 2000

Whole Grain Consumption and Risk of Ischemic Stroke in Women
JAMA 284:1534-1540, Liu,S. et al, 2000

Periodontal Disease and Risk of Cerebrovascular Disease
Arch Int Med 160:2749-2755, Wu,T.,et al, 2000

Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000

New Transient Ischemic Attack and Stroke
Arch Int Med 160:2941-2946, Goldstein,L.B.,et al, 2000

Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000

Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome?
Stroke 31:2597-2602, Thijs,V.N.,et al, 2000

Seizures After Stroke
Arch Neurol 57:1617-1622, Bladin,C.F.,et al, 2000

Clinicopath Conf, Granulomatous and Lymphocytic Hypophysitis
NEJM 343:1399-1406, Case 34-2000, 2000

Cardiac Involvement in Patients with Acute Neurologic Disease
Arch Int Med 160:3153-3158, Dixit,S.,et al, 2000

Diffusion-Weighted Imaging of Patients with Subacute Cerebral Ischemia: Comparison with Conventional and Contrast-Enhanced MR Imaging
AJNR 21:1596-1602,1569, Augustin,M.,et al, 2000

Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000

The Association Between the Diameter of a Patent Foramen Ovale and the Risk of Embolic Cerebrovascular Events
Am J Med 109:456-462,506, Schuchlenz,H.W.,et al, 2000

Interatrial Septal Abnormalities and Stroke
Neurol 55:1172-1179, Overell,J.R.,et al, 2000

Pulmonary Arteriovenous Malformations
Neurol 55:959-964, Moussouttas,M.,et al, 2000

Cost and Outcome of Mechanical Ventilation for Life-Threatening Stroke
Stroke 31:2346-2353, Mayer,S.A.,et al, 2000

Intake of Flavonoids, Carotenoids,Vitamins C and E, and Risk of Stroke in Male Smokers
Stroke 31:2301-2306, Hirvonen,T.,et al, 2000

Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications
Stroke 31:2407-2413, De Castro,S.,et al, 2000

Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000

Neurologic Manifestations of Infective Endocarditis
Arch Int Med 160:2781-2787, Heiro,M.,et al, 2000

Cardiac Arrhythmias and Stroke
Stroke 31:2925-2929, Engstrom,G.,et al, 2000

Familial Occipital Calcifications, hemorrhagic Strokes, Leukoencephalopathy, Dementia, and External Carotid Dysplasia
Neurol 55:1661-1667, Iglesias,S.,et al, 2000

Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000

Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000

An Overview of Acute Stroke Therapy
Arch Int Med 160:3196-3206, Fisher,M. & Schaebitz,W., 2000

Short-term Prognosis After Emergency Department Diagnosis of TIA
JAMA 284:2901-2906, Johnston,S.C.,et al, 2000

Stroke and Pregnancy
Stroke 31:2948-2951, Jaigobin,C. & Silver,F.L., 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000

Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke
Stroke 31:3067-3078, Bushnell,C.D. & Goldstein,L.B., 2000

Combined Perfusion- and Diffusion-Weighted MR Imagng in Acute Ischemic Stroke Durng the 1st Week: A Longitudinal Study
Radiology 217:886-894, Karnoen,J.O.,et al, 2000

Corpus Callosum Infarcts with Atypical Clinical and Radiologic Presentations
AJNR 21:1876-1880, Kasow,D.L.,et al, 2000

MR Imaging of the Cauda Equina in Hereditary Motor Sensory Neuropathies: Correlations with Sural Nerve Biopsy
AJNR 21:1793-1798,1779, Cellerini,M.,et al, 2000

Late Onset Postpartum Eclampsia Without Pre-Eclamptic Prodromi: Clinical and Neuroradiological Presentation in Two Patients
JNNP 69:824-827, Veltkamp,R.,et al, 2000

Contrast-Enhanced MR Angiography of Intracranial Giant Aneurysms
AJNR 21:1900-1907, Jager,H.R.,et al, 2000

Sturge-Weber Syndrome
Neurol 55:1472-1479, Arzimanoglou,A.A.,et al, 2000

Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000

Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000

Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000

When Drugs Don't Work
Neurol 55:1780-1784, Benbadis,S.R.,et al, 2000

Multifocal Dural Enhancement Associated with Temporal Arteritis
Arch Neurol 57:119-122, Joelson,E.,et al, 2000

Incidence of Postangiographic Abnormalities Revealed by Diffusion-Weighted MR Imaging
AJNR 21:55-59, Britt,P.M.,et al, 2000

Rate of Stroke Recurrence in Patients with Primary Intracerebral Hemorrhage
Stroke 31:123-127, Hill,M.D.,et al, 2000

Status Epilepticus In Stroke, Report on a Hospital-Based Stroke Cohort
Neurol 54:350-354, Rumbach,L.,et al, 2000

Effect of Poststroke Pyrexia on Stroke Outcome, A Meta-Analysis of Studies in Patients
Stroke 31:410-414, Hajat,C.,et al, 2000



Showing articles 3500 to 3550 of 7873 << Previous Next >>